S3V Vascular Technologies – Series B Funding from AM Naik, Madhusudan Kela & Others

Expert Analysis:

• S3V Vascular has secured Series B funding from prominent investors including L&T Chairman Emeritus A.M. Naik, Madhusudan Kela, Utpal Sheth (Rare Enterprises), and other ultra-high net worth individuals, reflecting strong institutional and investor confidence in the medical device import-substitution opportunity.​

• The company is establishing an integrated manufacturing facility to produce neurovascular devices including stent retrievers, microcatheters, and guidewires for India's stroke care market, with plans to scale production capacity significantly.​

• S3V's strategy includes pursuing international regulatory approvals (USFDA, CE certifications) to enable exports to Asia, Latin America, and Europe, and partnering with hospitals and public health systems including Ayushman Bharat to improve access to affordable thrombectomy procedures across India.​